Drug
PD 1 Inhibitor
PD 1 Inhibitor: highest development phase Phase 2, developed by Jiangsu Hengrui Medicine. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Jiangsu Hengrui Medicine
Trials
| Drug | Phase | Indication |
|---|---|---|
| PD-1 inhibitor NCT04922450 | Phase 2 | Head and Neck Cancer |
Latest
No recent events.
Follow PD 1 Inhibitor on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.